PilotaSaluteTesto originale in inglese
MS trial tests red blood cells to retrain immunity
The approach attaches specific proteins to patients’ own red blood cells before returning them to the body.
Scritto dall’IA1 fonte1 min
Loading…
Diagnosi, protesi, vaccini, genomica: la medicina che guadagna anni di vita.
La medicina che guadagna anni di vita: screening assistiti dall’IA che esaminano milioni di pazienti, vaccini di nuova generazione, una genomica che passa dal sequenziamento alla terapia, protesi e impianti che restituiscono capacità perdute. La rubrica segue le sperimentazioni cliniche concluse, le autorizzazioni all’immissione in commercio, le adozioni ospedaliere — il momento in cui una tecnologia smette di essere una pubblicazione per diventare una cura.
I numeri comandano: coorti, tassi di rilevamento, mortalità evitata, costi. Copriamo volentieri i sistemi sanitari che adottano su larga scala — l’India, il Brasile, il Sud-est asiatico — perché le tecnologie frugali si mettono spesso alla prova lì prima di arrivare altrove. Ogni articolo si appoggia alla sperimentazione, all’autorizzazione o allo studio che lo fonda, e li cita.
The approach attaches specific proteins to patients’ own red blood cells before returning them to the body.
At Saint Luke's Hospital, 54 hospitalized adults were randomly assigned to weighted-blanket or usual-care periods.
The study examined 61 healthy women aged 17–25 using stool sequencing and brain spectroscopy.
Clinicians can review notes, lab results, medicines and specialist records in some patient-chart workflows.
In a small study, ventilated COVID-19 patients received Auxora while researchers sampled their lungs.
The pain and touch signals looked similar in most cortical layers, but their blood-flow responses sharply diverged.
University of Utah researchers tested the approach in mouse models and human liver organoids.
NUS Medicine researchers traced heart damage to the loss of STMP1, a 47-amino-acid mitochondrial protein.
CameraJet will open for presales at 10 a.m. on September 7 for ¥3,899, with a camera, water flosser and AI recognition system.
Edinburgh researchers tested β-catenin, a cancer-linked protein, under two different buildup mechanisms.
The method distinguishes activated and quiescent immune cells without labels or destroying the sample.
The four-day treatment used organoids grown from mouse tumors and patient samples.
The estimate covers the United States from 1949 through 2024 and comes from a retrospective analysis.
Vanderbilt’s team found the liver kept releasing glucose at a later meal when morning glucagon was elevated.
An updated review covered 38 randomized trials involving 25,816 adults without diabetes.
A Rutgers trial followed 93 healthy women, 43% of them postmenopausal.
The 12-month regimen paired estriol, a pregnancy-associated estrogen, with progesterone.
Researchers identified 36 rare, risk-raising genes across OCD and chronic tic disorders.